Article
AMH in women with diminished ovarian reserve: potential differences by FMR1 CGG repeat level.
Journal of assisted reproduction and genetics - 1 Oct 2014
Pastore Lisa M, McMurry Timothy L, Williams Christopher D, Baker Valerie L, Young Steven L
Abstract excerpt
PURPOSE: We explored whether AMH, as a surrogate for oocyte supply, varies by FMR1 genotype in women diagnosed with diminished ovarian reserve (DOR), a subset of the Primary Ovarian Insufficiency phenotype. Research is inconsistent on the relationship between AMH and FMR1 repeat length, controlling for age. METHOD: Seventy-nine cycling women diagnosed with DOR, and without a family history of fragile X syndrome,...
Topics
- Adult
- Anti-Mullerian Hormone
- Female
- Follicle Stimulating Hormone
- Fragile X Messenger Ribonucleoprotein 1
- Fragile X Syndrome
- Genotype
- Humans
- Oocytes
- Ovarian Reserve
- Ovary
